Terazosin

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 27241-290
  • Package NDC 27241-290-01
  • Package NDC 27241-290-10
  • Application number ANDA219482
  • SPL ID ec1b00c3-3d59-420a-a71c-e9bd9a8d02fd
  • SPL set ID bed99c2a-4266-4a2c-bb0f-7643fdafff78
  • UNII D32S14F082
  • RxCUI 260376
  • RxCUI 313215
  • RxCUI 313217
  • RxCUI 313219

What the source publishes

Labeler
Ajanta Pharma USA Inc.
Active ingredients
Terazosin
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:27241-290_ec1b00c3-3d59-420a-a71c-e9bd9a8d02fd
{
  "name": "Terazosin",
  "splId": "ec1b00c3-3d59-420a-a71c-e9bd9a8d02fd",
  "labels": [
    {
      "setId": "bed99c2a-4266-4a2c-bb0f-7643fdafff78",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bed99c2a-4266-4a2c-bb0f-7643fdafff78",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bed99c2a-4266-4a2c-bb0f-7643fdafff78"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Ajanta Pharma USA Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 CAPSULE in 1 BOTTLE (27241-290-01)",
      "package_ndc": "27241-290-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250512"
    },
    {
      "sample": false,
      "description": "1000 CAPSULE in 1 BOTTLE (27241-290-10)",
      "package_ndc": "27241-290-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250512"
    }
  ],
  "productId": "27241-290_ec1b00c3-3d59-420a-a71c-e9bd9a8d02fd",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "27241-290",
  "deaSchedule": null,
  "genericName": "Terazosin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TERAZOSIN HYDROCHLORIDE",
      "strength": "5 mg/1"
    }
  ],
  "applicationNumber": "ANDA219482",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20250512",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0327241289019",
      "0327241291012",
      "0327241290015",
      "0327241288012"
    ],
    "unii": [
      "D32S14F082"
    ],
    "rxcui": [
      "260376",
      "313215",
      "313217",
      "313219"
    ],
    "spl_set_id": [
      "bed99c2a-4266-4a2c-bb0f-7643fdafff78"
    ],
    "manufacturer_name": [
      "Ajanta Pharma USA Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:27241-290_ec1b00c3-3d59-420a-a71c-e9bd9a8d02fd"